Press coverage about Check Cap (NASDAQ:CHEK) has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of media coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Check Cap earned a daily sentiment score of 0.06 on Accern’s scale. Accern also assigned news headlines about the medical research company an impact score of 45.6075196480123 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
CHEK stock traded down $0.05 on Wednesday, reaching $0.60. The company’s stock had a trading volume of 109,151 shares, compared to its average volume of 275,229. The stock has a market cap of $12.71, a P/E ratio of -0.98 and a beta of -0.22. Check Cap has a one year low of $0.57 and a one year high of $2.38.
CHEK has been the topic of several recent analyst reports. HC Wainwright reduced their price target on Check Cap from $7.00 to $5.50 and set a “buy” rating on the stock in a report on Tuesday, November 28th. Zacks Investment Research upgraded Check Cap from a “hold” rating to a “buy” rating and set a $1.00 price target on the stock in a report on Monday, January 15th.
WARNING: This story was posted by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are viewing this story on another domain, it was stolen and reposted in violation of United States and international trademark and copyright laws. The original version of this story can be accessed at https://www.thelincolnianonline.com/2018/03/21/check-cap-chek-getting-somewhat-favorable-media-coverage-report-shows.html.
Check Cap Company Profile
Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.
Receive News & Ratings for Check Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check Cap and related companies with MarketBeat.com's FREE daily email newsletter.